Literature DB >> 21954631

The prospects of medical application of metal-based nanoparticles and nanomaterials.

I S Chekman1, Z R Ulberg, N O Gorchakova, T Yu Nebesna, T G Gruzina, A O Priskoka, A M Doroshenko, P V Simonov.   

Abstract

Current studies, dedicated to metallic (gold, silver, iron, and copper) nanomaterials are reviewed in this paper. This metals own unique physical and chemical properties which determine their application. The medical application of metallic nanomaterials includes therapy and prophylaxis of diseases, development of new drugs and improvement of conventional ones, nanodiagnostics. Nevertheless some aspects concerning the introduction of the nanometals into medical practice need further profound research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21954631

Source DB:  PubMed          Journal:  Lik Sprava        ISSN: 1019-5297


  4 in total

1.  Synergistic effect of a LPEMF and SPIONs on BMMSC proliferation, directional migration, and osteoblastogenesis.

Authors:  Shaoyu Wu; Qiang Yu; Yang Sun; Jing Tian
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

2.  Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology.

Authors:  Mykola Ya Spivak; Rostyslav V Bubnov; Ilya M Yemets; Liudmyla M Lazarenko; Natalia O Tymoshok; Zoia R Ulberg
Journal:  EPMA J       Date:  2013-07-29       Impact factor: 6.543

Review 3.  Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems.

Authors:  Marziyeh Hajialyani; Devesh Tewari; Eduardo Sobarzo-Sánchez; Seyed Mohammad Nabavi; Mohammad Hosein Farzaei; Mohammad Abdollahi
Journal:  Int J Nanomedicine       Date:  2018-09-03

4.  Study of the biological effectiveness of a nanosilver-epidermal growth factor sustained-release carrier.

Authors:  Jian-DA Zhou; Shao-Hua Wang; Rui Liu; Chun-Jiao Zhou; Ke Cao; Jin-Yan Liu; Yao Chen; Feng-Hua Chen
Journal:  Exp Ther Med       Date:  2013-02-06       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.